Baxter (NYSE:BAX) shares slipped today in pre-market trading after the healthcare giant posted third-quarter sales that missed the consensus forecast on Wall Street and cut its sales outlook for the rest of the year. Chicago-area Baxter posted profits of $544 million, or $1 even per share, on sales of $2.77 billion for the three months ended […]
Baxter wins CE Mark for PrisMax continuous renal replacement system, TherMax blood warmer
Baxter (NYSE:BAX) said today that it won CE Mark approval in the European Union for its PrisMax continuous renal replacement system and TherMax blood warmer. The newly cleared PrisMax system is the company’s next-gen renal replacement and organ support therapy tech, and is intended to supply a range of extracorporeal therapies to remove waste products, excess […]
Baxter, Mayo Clinic ink collab deal to develop US-based renal care center
Baxter (NYSE:BAX) said today that it inked a collaborative deal with the Mayo Clinic to develop a new renal care center of excellence in the US. The new renal care center will be located at the Mayo Clinic’s dialysis center in Jacksonville, Fla., Baxter said, and will integrate Baxter’s Renal Care Services clinical service model and […]
FDA clears Baxter’s Altapore bone graft for spinal indications
Baxter (NYSE:BAX) said today it won FDA clearance for its Altapore bioactive bone graft, indicated for use as an autograft extender in posterolateral spinal fusion. The Altapore bone graft is designed to enhance bone growth and features improved porosity which the company said promotes earlier vascularization and can improve the bone formation process. Baxter said that […]
Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
The 20 largest medical device companies in the world
The medical device industry saw even more consolidation over the past year, as evidenced by Medical Design & Outsourcing‘s newest Big 100 list. It used to be that a company had to have at least $100 million in annual revenue to make it on the list. This time around, No. 100 on the list is […]
The 10 largest medtech employers of 2018 – and what their employees really think
Among the 10 largest medtech employers, workers feel pride in working on life-saving products – but there’s also frustration with big corporate bureaucracy. That was the major takeaway as Medical Design & Outsourcing compiled some of the most insightful current and former employee reviews posted on Glassdoor. The 10 companies we’re counting down were the largest […]
Baxter wins FDA nod for Actifuse Flow bone graft substitute
Baxter (NYSE:BAX) said today it won FDA clearance for its Actifuse Flow bone graft substitute, indicated for use in a variety of orthopedic surgical procedures. The Actifuse Flow graft uses proprietary silicate-substituted technology from the Deerfield, Ill.-based company’s Actifuse bone graft substitute, intended to enhance silicon levels to accelerate bone formation. The newly cleared graft requires […]
CHF Solutions takes Aquadex manufacturing in-house
CHF Solutions (NSDQ:CHFS) said it has finished transferring all manufacturing for the Aquadex FlexFlow fluid filtration system to its Eden Prairie, Minn. plant. CHF acquired the Aquadex device in 2016 for $5 million from Baxter (NYSE:BAX), which had been the contract manufacturer of CHF products. CHF began the manufacturing transfer in June 2017 and completed it by beginning […]
Baxter wins CE Mark for Evo IQ infusion system
Baxter (NYSE:BAX) said today that its Evo IQ infusion system won CE Mark clearance and regulatory approval in Australia. The company plans to start the launch process for its infusion system in the U.K., Ireland, New Zealand and Australia in the third quarter of this year. Get the full story at our sister site, Drug Delivery […]
Baxter shares dip despite Q2 earnings beat
Shares in Baxter (NYSE:BAX) have fallen slightly today despite the medical giant beating expectations on Wall Street with its second quarter earnings results. The Deerfield, Ill.-based company posted profits of $343 million, or 63¢ per share, on sales of $2.8 billion for the three months ended June 30, seeing profits grow 29.4% while sales grew 9.1% […]
- 1
- 2
- 3
- …
- 26
- Next Page »
MassDevice Network
@MassDevice
LinkedIn